Andrew Gentry, PharmD
Andrew Gentry, PharmD is a PGY-1 pharmacy resident at John Dempsey Hospital/UConn Health, Farmington, CT.
Ocrelizumab for Multiple Sclerosis
Ocrelizumab for Multiple Sclerosis
The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
FDA approves Epclusa (sofosbuvir/velpatasvir) for chronic hepatitis C infection
FDA approved EpclusaTM (sofosbuvir and velpatasvir, (SOF-VEL) for adults with chronic hepatitis C infection both with compensated cirrhosis or without cirrhosis as well as in combination with ribavirin for hepatitis C with decompensated cirrhosis.

Poll